Oligonucleotide Synthesis Market Demonstrates Long-Term Growth Potential At 17.1% CAGR

The oligonucleotide synthesis market is poised for significant expansion over the coming years, driven by advancements in biotechnology and growing demand across therapeutic and diagnostic fields. As technologies evolve and investments increase, this sector is set to experience strong momentum through 2030.

Projected Market Size and Growth Rate of the Oligonucleotide Synthesis Market
The oligonucleotide synthesis market is anticipated to reach a valuation of $26.08 billion by 2030. This growth reflects a robust compound annual growth rate (CAGR) of 17.1%. Key factors contributing to this surge include intensified use in therapeutic and diagnostic applications, widespread adoption of automated synthesis platforms, progress in gene therapy research, rising investments in biotechnology, and global expansion of oligonucleotide-based research and diagnostics. Emerging trends shaping the market encompass developments in gene editing and personalized medicine, deployment of cloud-based data management solutions, AI-driven sequence optimization, enhanced automation in synthesis processes, and the utilization of IoT technology for equipment monitoring and process oversight.

The oligonucleotide synthesis market size has grown rapidly in recent years. It will grow from $11.92 billion in 2025 to $13.9 billion in 2026 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to high cost of synthesis equipment, limited availability of custom oligos, dependency on manual synthesis processes, low awareness among researchers, lengthy production timelines.

Download a free sample of the oligonucleotide synthesis market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12176&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Top Companies Leading the Oligonucleotide Synthesis Market
Several prominent organizations dominate the oligonucleotide synthesis field. These include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Nitto Denko Avecia Inc., Alnylam Pharmaceuticals Inc., Maravai Life Sciences, LGC Limited, Ionis Pharmaceuticals Inc., GenScript Inc., Ajinomoto Bio-Pharma Services, Sarepta Therapeutics Inc., Integrated DNA Technologies Inc., Twist Bioscience Corporation, Eurogentec SA, Kaneka Eurogentec S.A., Biocomma Limited, Bio-Synthesis Inc., TriLink BioTechnologies Incorporated, Generi Biotech s.r.o., ATDBio Ltd., BioAutomation Corporation, Biolegio B.V., and Dharmacon Research Inc.

Significant Acquisition Strengthening Market Capabilities
In June 2024, the UK-based pharmaceutical giant GSK plc expanded its footprint in oligonucleotide technologies by acquiring Elsie Biotechnologies for $50 million. This acquisition enables GSK to fully integrate Elsie's expertise in oligonucleotide discovery, synthesis, and delivery into its research and development operations. Elsie Biotechnologies, a US-based firm specializing in oligonucleotide therapeutics, is expected to enhance GSK's capabilities in creating advanced oligonucleotide medicines.

View the full oligonucleotide synthesis market report:
https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Innovations and Market Trends Driving Oligonucleotide Synthesis
Market leaders are increasingly focused on creating cutting-edge DNA products that improve sequence fidelity, streamline workflows, and empower advanced scientific studies. For instance, in July 2024, US-based Ansa Biotechnologies introduced Ansa Clonal DNA and Ansa DNA Fragments. Ansa Clonal DNA offers clonal, sequence-accurate DNA up to 600 base pairs, eliminating the need for assembly and delivering unparalleled precision for synthetic biology tasks. This product guarantees error-free, ready-to-use DNA sequences, making it highly reliable for researchers. Meanwhile, Ansa DNA Fragments provides sequence-verified linear double-stranded DNA fragments up to 600 base pairs, designed for a wide range of research applications. The company's enzymatic synthesis technology allows the production of complex DNA constructs, including difficult repeats and secondary structures, with exceptional accuracy.

Key Segmentation Areas in the Oligonucleotide Synthesis Market Report
This report segments the oligonucleotide synthesis market across several critical categories:
1) By Type: Custom Oligos and Predesigned Oligos
2) By Solution Type: Oligonucleotides, Reagents, Equipment, Services, Purification, and Modification
3) By Application: Therapeutic, Research, and Diagnostic Applications

Further breakdowns are provided within these segments, such as:
- Custom Oligos: Long Oligonucleotides, Short Oligonucleotides, Modified Oligonucleotides
- Predesigned Oligos: Gene-Specific Oligos, Probe Oligos, and Primers for PCR and RT-PCR

This detailed segmentation offers a comprehensive understanding of the market's structure and areas of focus.

New strategic additions in our 2026 market reports include market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.